GC
DARA

Guggenheim Capital’s DARA BIOSCIENCES INC COM STK (DE) DARA Stock Holding History

Guggenheim Capital’s Portfolio DARA Stock Details DARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,072
Closed -$8K – 3433
2013
Q4 		$8K Buy
3,072
+182
+6% +$475 ﹤0.01% 3170
2013
Q3 		$7K Hold
2,890
– – ﹤0.01% 3053
2013
Q2 		$9K Buy
+2,890
New +$10.7K ﹤0.01% 3020

Other funds holding DARA

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FNYS
First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $126M AUM 15.32% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
FNBOMD
First National Bank of Mount Dora Mount Dora, Florida $499M AUM 22.75% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Guggenheim Capital's DARA Position: Q1 2014 in Review

Guggenheim Capital sold out of DARA BIOSCIENCES INC COM STK (DE) (DARA) in Q1 2014, closing a stake of 3,072 shares — an estimated $8K sold.

Guggenheim Capital first reported a position in DARA in Q2 2013 and held it in 3 quarters. The position peaked at $9K in Q2 2013. 15 funds tracked by Wall St. Rank hold DARA as of Q1 2014.

  • Guggenheim Capital reported no remaining DARA BIOSCIENCES INC COM STK (DE) position as of Q1 2014 after selling out during the quarter.
  • Guggenheim Capital sold 3,072 DARA BIOSCIENCES INC COM STK (DE) shares in Q1 2014, an estimated $8K.
  • Guggenheim Capital first reported a position in DARA BIOSCIENCES INC COM STK (DE) in Q2 2013 and held it in 3 quarters.
  • Guggenheim Capital's DARA BIOSCIENCES INC COM STK (DE) position peaked at $9K in Q2 2013.
  • 15 funds tracked by Wall St. Rank held DARA BIOSCIENCES INC COM STK (DE) as of Q1 2014.

Based on Guggenheim Capital's 13F filing for Q1 2014, filed 16 May 2014.